Award-winning journalist Jon Palfreman, author of Brain Storms: The Race to Unlock the Mysteries of Parkinson's Disease, discusses the science behind this mysterious disease
A hormone involved in circadian rhythms could provide treatment for the autoimmune disease
Scientific American MIND speaks with the author of Brain Storms: The Race to Unlock the Mysteries of Parkinson’s Disease
Deficiencies in zinc can play a role in depression and a new way to enhance lithium may hold promise for bipolar disorder
Your nightly rest turns out to affect your mind and health more than anyone suspected
The substance appears to be involved in a number of social and sensory processes that go awry in people with autism spectrum disorder
Study raises question about whether proteins implicated in the disease are capable of spreading through medical procedures
Animal experiments show how a just-discovered prion triggers a rare Parkinson’s-like disease
The famed neurologist–author found uniqueness in every patient and savored the miracle of existence, whether it be found in squirrel monkeys or people
The prolific author–neurologist gave the world empathetic insights into disorders of the brain while also inspiring films, plays, an opera and likely many careers in medicine and brain science...
The brain constantly strives to reconcile its own internal picture of the world with the incoming sensory flood from eyes, ears and other sensory inputs— a process that lets us run, walk and move about the world...
Neurons involved in Parkinson’s disease are especially susceptible to burnout because of their complex branching
Far more than a nervous habit, body-focused repetitive behaviors may be a response to boredom and frustration
Although several therapies have shown some success in helping people exposed to traumatic experiences, not everyone recovers equally well
If you seek high well-being, your best bets are gratitude and love of learning.
Telltale differences in the brain and immune system before deployment may predict which soldiers are most likely to succumb later on
The second-most common form of dementia has been difficult to study without a better understanding of early symptoms
Congress members from both sides of the aisle are calling for a national strategy to confront the dementia “tsunami” but let’s be real about what to expect
After a string of failed trials, drugs that target protein build-up in the brain appear to slow disease progress
The new line of communication prompts rethinking of neurologic disease
